uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Reasanz
Refused
Human
Details
EMA number
EMEA/H/C/002817
ATC code
C01DX21
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of acute heart failure
MeSH:
Heart Failure
Group:
Other vasodilators used in cardiac diseases
Active substances
serelaxin
Marketing Authorisation Holder
Novartis Europharm Ltd
MAH
Reasanz | uMedical